The Effects of TMZ on Diabetic Nephropathy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT05147194
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT05147194
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT05147194. Randomized; no masking; primary purpose treatment. Start 2022-01-01 (anticipated); primary completion 2023-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Effects of TMZ on Diabetic Nephropathy
- Condition
- Diabetic Nephropathies
- Intervention (Drug)
- Trimetazidine
- Lead sponsor
- Tongji Hospital
Record details
- Record id
cardio:ct-nct05147194- Content hash
122a61050e84b5855337466c830184b7ae6a7329b60683eab8f5d482a390a451